Montserrat M. Diaz
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Identification of early predictors of clinical remission in primary membranous nephropathy: a post hoc analysis of the STARMEN trial.
Journal: Clinical kidney journal
Published: November 22, 2024
A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study.
Journal: Nefrologia
Published: October 17, 2024
Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome.
Journal: Journal of clinical medicine
Published: October 10, 2024
Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT).
Journal: Journal of clinical medicine
Published: September 25, 2024
Highlights from the breakout session: advances in treatment II.
Journal: Rheumatology (Oxford, England)
Published: July 08, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Journal: Journal of the American Society of Nephrology : JASN
Published: June 16, 2024
The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes.
Journal: Clinical kidney journal
Published: December 19, 2022
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome.
Journal: Kidney international
Published: December 02, 2022
Risk factors for non-diabetic renal disease in diabetic patients.
Journal: Clinical kidney journal
Published: August 24, 2019
Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy.
Journal: Clinical kidney journal
Published: May 26, 2018
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.
Journal: Kidney international reports
Published: June 22, 2016
Last Updated: 09/26/2026